Integral Molecular Launches MPS Platform for Discovery of Antibodies Targeting ... Business Wire (press release) MPSTM enables the isolation, characterization, and engineering of monoclonal antibodies (MAbs) against difficult membrane protein targets including GPCRs, transporters and ion channels. The technology platform harnesses the strength of Integral's ... |
